Fatal Case of Rhabdomyolysis Post-COVID-19 Vaccine
| Autor: | Kunal M Ajmera |
|---|---|
| Jazyk: | angličtina |
| Rok vydání: | 2021 |
| Předmět: |
Pharmacology
2019-20 coronavirus outbreak medicine.medical_specialty Coronavirus disease 2019 (COVID-19) business.industry Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) COVID-19 vaccines Case Report medicine.disease Infection rate autoimmune disorders Infectious Diseases Pandemic medicine rhabdomyolysis Pharmacology (medical) Risk factor business Intensive care medicine Adverse effect Rhabdomyolysis |
| Zdroj: | Infection and Drug Resistance |
| ISSN: | 1178-6973 |
| Popis: | Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) or COVID-19 pandemic has taken away the lives of many people (>4 million per WHO) around the world as of July 2021. With the advancement of the vaccine against COVID-19, in less than a year since the start of the pandemic, the infection rate has come under control in certain regions but is still rising in many more. However, with time, we are also learning a lot more about the adverse events related to the vaccine. This report documents the first fatal case of rhabdomyolysis potentially associated with the COVID-19 vaccine and supports the possibility that autoimmunity is a major risk factor for covid vaccine-related rhabdomyolysis. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|